• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在部分印度 SARS-CoV-2 基因组中,包膜糖蛋白的 C 末端区域缺失。

Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.

机构信息

Division of Infectious Diseases, Nitte University Centre for Science Education and Research, Nitte (Deemed to be University), Deralakatte, Mangaluru, 575018, India.

Department of Microbiology, The Madras Medical Mission, 4-A, Dr, Mogappair, Chennai, Tamil Nadu, 600037, India.

出版信息

Virus Res. 2021 Jan 2;291:198222. doi: 10.1016/j.virusres.2020.198222. Epub 2020 Nov 6.

DOI:10.1016/j.virusres.2020.198222
PMID:33166565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7645280/
Abstract

The envelope glycoprotein (E) is the smallest structural component of SARS-CoVs; plays an essential role in the viral replication starting from envelope formation to assembly. The in silico analysis of 2086 whole genome sequences from India performed in this study provides the first observation on the extensive deletion of amino acid residues in the C-terminal region of the envelope glycoprotein in 34 Indian SARS-CoV-2 genomes. These amino acid deletions map to the homopentameric interface and PDZ binding motif (PBM) present in the C-terminal region of E protein as well as immediately after the reverse primer binding region as per Charité protocol in 26 of these genomes, hence, their detection through RT-qPCR may not be hampered and therefore E gene-based RT-qPCR would still detect these isolates. Eight genomes from the State of Odisha had deletion even in the primer binding site. It is possible that the deletions in the C-terminal region of E protein of these genomes are a result of adapting to a newer geographical area and host. The information on the clinical status was available only for 9 out of 34 cases and these were asymptomatic. However, further studies are indispensable to understand the functional consequences of amino acid deletion in the C terminal region of SARS-CoV-2 envelope protein in the viral pathogenesis and host adaptation.

摘要

包膜糖蛋白(E)是 SARS-CoV 中最小的结构成分;在从包膜形成到组装的病毒复制过程中起着至关重要的作用。本研究对印度 2086 个全基因组序列进行了计算机分析,首次观察到 34 个印度 SARS-CoV-2 基因组中包膜糖蛋白 C 末端区域的氨基酸残基广泛缺失。这些氨基酸缺失位于 E 蛋白 C 末端的同源五聚体界面和 PDZ 结合基序(PBM)以及根据 Charité 方案在 26 个基因组中逆转录引物结合区域之后,因此,通过 RT-qPCR 检测不会受到阻碍,因此基于 E 基因的 RT-qPCR 仍将检测到这些分离株。来自奥里萨邦的 8 个基因组甚至在引物结合位点都有缺失。这些基因组中 E 蛋白 C 末端的缺失可能是为了适应新的地理区域和宿主。关于临床状况的信息仅可用于 34 例中的 9 例,且这些都是无症状的。然而,进一步的研究对于理解 SARS-CoV-2 包膜蛋白 C 末端氨基酸缺失在病毒发病机制和宿主适应中的功能后果是必不可少的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/7645280/d2f20c7ad2ab/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/7645280/d2f20c7ad2ab/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/825d/7645280/d2f20c7ad2ab/gr1_lrg.jpg

相似文献

1
Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.在部分印度 SARS-CoV-2 基因组中,包膜糖蛋白的 C 末端区域缺失。
Virus Res. 2021 Jan 2;291:198222. doi: 10.1016/j.virusres.2020.198222. Epub 2020 Nov 6.
2
How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection?如何选择用于 SARS-CoV-2 基因组检测的合适实时 RT-PCR 引物?
J Virol Methods. 2021 Sep;295:114197. doi: 10.1016/j.jviromet.2021.114197. Epub 2021 May 24.
3
SARS-CoV2 envelope protein: non-synonymous mutations and its consequences.SARS-CoV2 包膜蛋白:非同义突变及其后果。
Genomics. 2020 Nov;112(6):3890-3892. doi: 10.1016/j.ygeno.2020.07.001. Epub 2020 Jul 5.
4
Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence.SARS-CoV PBM 与细胞 PDZ 结构域相互作用导致病毒毒力。
Viruses. 2024 Jul 29;16(8):1214. doi: 10.3390/v16081214.
5
Coronavirus virulence genes with main focus on SARS-CoV envelope gene.主要聚焦于严重急性呼吸综合征冠状病毒包膜基因的冠状病毒毒力基因。
Virus Res. 2014 Dec 19;194:124-37. doi: 10.1016/j.virusres.2014.07.024. Epub 2014 Aug 2.
6
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.出现一种nsp1基因有缺失的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒株。
J Transl Med. 2020 Aug 31;18(1):329. doi: 10.1186/s12967-020-02507-5.
7
Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study.利用包膜(E)蛋白开发针对 SARS-CoV2 的新型疫苗靶点:基于进化、分子建模和对接的研究。
Int J Biol Macromol. 2021 Mar 1;172:74-81. doi: 10.1016/j.ijbiomac.2020.12.192. Epub 2020 Dec 29.
8
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.SARS-CoV-2 的包膜和膜蛋白调节刺突蛋白的成熟和保留,从而允许病毒样颗粒的组装。
J Biol Chem. 2021 Jan-Jun;296:100111. doi: 10.1074/jbc.RA120.016175. Epub 2020 Dec 3.
9
Towards Determining the Epitopes of the Structural Proteins of SARS-CoV-2.探索 SARS-CoV-2 结构蛋白表位。
Methods Mol Biol. 2022;2410:265-272. doi: 10.1007/978-1-0716-1884-4_12.
10
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.SARS-CoV-2 包膜、膜、核衣壳和刺突结构蛋白在大流行开始到 2020 年 9 月期间的演变:按流行病学周进行的全球和区域方法。
Viruses. 2021 Feb 4;13(2):243. doi: 10.3390/v13020243.

引用本文的文献

1
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.SARS-CoV-2 的结构蛋白和非结构蛋白:COVID-19 治疗或预防相关疾病进展的潜在方面。
Cell Commun Signal. 2023 May 15;21(1):110. doi: 10.1186/s12964-023-01104-5.
2
Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis.Toll样受体2和9基因多态性对COVID-19的影响:易感性、严重程度和血栓形成
J Inflamm Res. 2023 Feb 17;16:665-675. doi: 10.2147/JIR.S394927. eCollection 2023.
3
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination.

本文引用的文献

1
Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.基因组流行病学揭示了 SARS-CoV-2 在印度卡纳塔克邦的多次传入和传播。
PLoS One. 2020 Dec 17;15(12):e0243412. doi: 10.1371/journal.pone.0243412. eCollection 2020.
2
A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.印度严重急性呼吸综合征冠状病毒2分离株的一个独特系统发育簇。
Open Forum Infect Dis. 2020 Sep 18;7(11):ofaa434. doi: 10.1093/ofid/ofaa434. eCollection 2020 Nov.
3
A SARS-CoV-2 variant with the 12-bp deletion at E gene.
宿主遗传多样性和 SARS-CoV-2 的遗传变异在 COVID-19 发病机制和疫苗效力中的作用。
Int Immunopharmacol. 2022 Oct;111:109128. doi: 10.1016/j.intimp.2022.109128. Epub 2022 Aug 8.
4
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.SARS-CoV-2 变体的分子特征、免疫逃逸及其影响。
Signal Transduct Target Ther. 2022 Jun 28;7(1):202. doi: 10.1038/s41392-022-01039-2.
5
Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins-A Possible Signature of Adaptive Selection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白高变区插入缺失频率增加——适应性选择的一种可能特征
Front Genet. 2022 Jun 2;13:875406. doi: 10.3389/fgene.2022.875406. eCollection 2022.
6
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.靶向刺突蛋白上两个免疫优势表位的单克隆抗体可中和新型 SARS-CoV-2 关切变异株。
EBioMedicine. 2022 Feb;76:103818. doi: 10.1016/j.ebiom.2022.103818. Epub 2022 Jan 22.
7
Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion.从乌拉圭新冠肺炎病例传播集群看新型 SARS-CoV-2 ORF6 缺失的出现和扩散
Mem Inst Oswaldo Cruz. 2022 Jan 10;116:e210275. doi: 10.1590/0074-02760210275. eCollection 2022.
8
Reliable Diagnostics of SARS-CoV-2 Infections Using One- and Two-Gene Molecular Tests for a Viral RNA Detection-Results Questioning Previous Observations.使用单基因和双基因分子检测进行病毒RNA检测以可靠诊断SARS-CoV-2感染——结果对先前观察提出质疑
Diagnostics (Basel). 2021 Oct 5;11(10):1839. doi: 10.3390/diagnostics11101839.
9
SARS-CoV-2 one year on: evidence for ongoing viral adaptation.SARS-CoV-2 一年来的发展:病毒持续适应的证据。
J Gen Virol. 2021 Apr;102(4). doi: 10.1099/jgv.0.001584.
10
SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants.SARS-CoV-2 基因组学:对病毒变异进行测序的印度视角。
J Biosci. 2021;46(1). doi: 10.1007/s12038-021-00145-7.
一种带有 E 基因 12 个碱基缺失的 SARS-CoV-2 变体。
Emerg Microbes Infect. 2020 Dec;9(1):2361-2367. doi: 10.1080/22221751.2020.1837017.
4
A vulnerability index for the management of and response to the COVID-19 epidemic in India: an ecological study.印度 COVID-19 疫情管理和应对的脆弱性指数:一项生态学研究。
Lancet Glob Health. 2020 Sep;8(9):e1142-e1151. doi: 10.1016/S2214-109X(20)30300-4. Epub 2020 Jul 16.
5
Evaluation of & -based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.基于&的实时逆转录聚合酶链反应检测法用于确诊新型冠状病毒2019感染的评估:一项观察性研究。 (注:原文中“&”处信息缺失,可能影响对完整内容的准确理解)
Indian J Med Res. 2020 May;151(5):483-485. doi: 10.4103/ijmr.IJMR_1256_20.
6
Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic.严重急性呼吸综合征冠状病毒2与2019新型冠状病毒病:一场非凡的大流行。
Lung India. 2020 May-Jun;37(3):268-271. doi: 10.4103/lungindia.lungindia_170_20.
7
Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India.对从意大利、伊朗和中国返回的印度人以及在印度的意大利游客中新冠病毒2型毒株的基因组分析。
Indian J Med Res. 2020;151(2 & 3):255-260. doi: 10.4103/ijmr.IJMR_1058_20.
8
Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments.新型冠状病毒(2019-nCoV)的现状,基于基因组分析的进化视角及最新进展。
Vet Q. 2020 Dec;40(1):68-76. doi: 10.1080/01652176.2020.1727993.
9
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.中国新型冠状病毒(2019-nCoV)的基因组组成和分化。
Cell Host Microbe. 2020 Mar 11;27(3):325-328. doi: 10.1016/j.chom.2020.02.001. Epub 2020 Feb 7.
10
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.